✦ LIBER ✦

Methotrexate Conjugates: A Molecular In Vivo Protein Tag

✍ Scribed by Lawrence W. Miller; Julia Sable; Philip Goelet; Michael P. Sheetz; Virginia W. Cornish

Book ID: 101560218
Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 139 KB
Volume: 43
Category: Article
ISSN: 0044-8249
DOI: 10.1002/anie.200352852

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Methotrexate Conjugates: A Molecular In

Methotrexate Conjugates: A Molecular In Vivo Protein Tag

✍ Lawrence W. Miller; Julia Sable; Philip Goelet; Michael P. Sheetz; Virginia W. C 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 138 KB

In vivo protein labeling with trimethopr

In vivo protein labeling with trimethoprim conjugates: a flexible chemical tag

✍ Miller, Lawrence W; Cai, Yunfei; Sheetz, Michael P; Cornish, Virginia W 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 265 KB

Enzymatic protein conjugation in vivo

✍ Kanako Wakamura; Tsutomu Tanaka; Akihiko Kondo 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Bone Affinity of a Bisphosphonate-Conjug

Bone Affinity of a Bisphosphonate-Conjugated Protein in Vivo

✍ Hasan Uludag; Tiejun Gao; Gregory R. Wohl; Darko Kantoci; Ronald F. Zernicke 📂 Article 📅 2000 🏛 American Institute of Chemical Engineers 🌐 English ⚖ 709 KB

Conjugation of methotrexate to IgG antib

Conjugation of methotrexate to IgG antibodies and their F(ab)2fragments and the effect of conjugated methotrexate on tumor growth in vivo

✍ Padmaja N. Kulkarni; A. Huntley Blair; Tarunendu Ghose; Molly Mammen 📂 Article 📅 1985 🏛 Springer-Verlag 🌐 English ⚖ 422 KB

Pre-clinical evaluation of a methotrexat

Pre-clinical evaluation of a methotrexate–albumin conjugate (MTX-HSA) in human tumor xenografts in vivo

✍ Angelika M. Burger; Gernot Hartung; Gerd Stehle; Hannsjörg Sinn; Heinz Herbert F 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 127 KB

Methotrexate covalently bound to human serum albumin in a 1:1 molar ratio (MTX-HSA) is a new macromolecular drug which is currently being studied in phase I clinical trials by the German Association for Medical Oncology (AIO) Phase I/II study group. Previous studies have shown that MTX-HSA differs f